Read + Share
Amedeo Smart
Independent Medical Education
Szydlowski M, Garbicz F, Jablonska E, Gorniak P, et al. Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies. Cancer Res 2021;81:6029-6043.PMID: 34625423
Email
LinkedIn
Facebook
Twitter
Privacy Policy